India to launch HPV vaccination for girls aged 14

The HPV vaccination is most effective when administered before the start of sexual activity, as this is when individuals are most susceptible to HPV infection. Targeting girls aged 14 aims to provide protection before potential exposure to the virus. Also, focusing on a specific age group allows for efficient resource allocation and program implementation.

For Prelims, remember that HPV types 16 and 18 are responsible for more than 80% of cervical cancer cases in India. Also, note that nearly 80,000 new cases are reported annually, leading to over 42,000 deaths. The vaccine being used is Gardasil, a quadrivalent vaccine.

This program aligns with India's commitment to preventive healthcare and reducing the burden of non-communicable diseases (NCDs). It also contributes to achieving Sustainable Development Goal (SDG) 3, which focuses on ensuring healthy lives and promoting well-being for all ages. Furthermore, it complements the Universal Immunization Programme by expanding vaccine coverage to address a significant health issue affecting women.

Challenges may include ensuring adequate vaccine supply and distribution, addressing vaccine hesitancy and misinformation, reaching girls in remote or underserved areas, and maintaining consistent program monitoring and evaluation. Effective communication strategies and community engagement will be crucial to overcome these challenges.

A 'critically examine' answer should include both the benefits and potential drawbacks. Benefits include reduced cervical cancer incidence and mortality. Drawbacks could include the cost of the vaccine, logistical challenges in reaching all eligible girls, and the potential for vaccine hesitancy. Also, discuss whether a voluntary program is as effective as a mandatory one.

A quadrivalent vaccine protects against four HPV types (6, 11, 16, and 18), while a bivalent vaccine protects against two (typically 16 and 18). Gardasil protects against both cervical cancer-causing types (16 and 18) and types that cause genital warts (6 and 11). The choice of Gardasil might be due to its broader protection or availability and cost considerations.

By addressing a cancer that disproportionately affects women, the program can help reduce gender disparities in health outcomes. It also signals a commitment to prioritizing women's health needs. However, it's important to ensure equitable access to the vaccine across all socioeconomic groups to avoid exacerbating existing inequalities.

This topic is most relevant to GS Paper II (Social Justice and Governance) and GS Paper III (Health). In GS Paper II, it relates to issues of women's health, gender inequality, and government policies for vulnerable sections. In GS Paper III, it falls under the umbrella of public health, disease prevention, and government initiatives in the health sector.

While respecting individual autonomy, a voluntary program may face lower uptake rates compared to a mandatory one. Success depends on effective public awareness campaigns to address vaccine hesitancy and promote informed decision-making. The government needs to actively encourage participation through education and community engagement.

Aspirants should monitor the program's rollout, coverage rates, and any challenges encountered during implementation. Also, pay attention to public perception and any controversies that may arise. Tracking the program's impact on cervical cancer incidence in the long term will also be crucial.